Atazanavir And Cobicistat + Encorafenib Interaction
Contraindicatedinteraction on record
Description
encorafenib ↓ atazanavir ↓ cobicistat ↑ encorafenib Coadministration with encorafenib is contraindicated due to the potential for loss of virologic response of EVOTAZ, development of resistance, and risk of serious adverse events such as QT interval prolongation. Mechanism: The mechanism of interaction is CYP3A4 induction by encorafenib.
Source: FDA drug label - atazanavir and cobicistat